Skip to main content

Table 1 Clinical characteristics of patients with pulmonary sclerosing pneumocytoma (N = 61)

From: Pulmonary sclerosing pneumocytoma: clinical features and prognosis

Characteristics

All (n = 61)

Sublobectomy (n = 36)

Lobectomy (n = 25)

P value

Age, year

   

0.359

 Mean ± SD

51.90 (12.40)

50.67 (12.13)

53.68 (13.06)

 

 Median (range)

51 (23-73)

51.5 (23-69)

55 (23-73)

 

Sex, n (%)

   

1.000

 Male

5 (8.20)

3 (8.33)

2 (8)

 

 Female

56 (91.80)

33 (91.67)

23 (92)

 

BMIa, kg/m2

22.69 (2.48)

22.50 (2.19)

22.95 (2.92)

0.494

Smoking history, n (%)

   

0.430

 Ever

7(11.48)

3 (8.33)

4 (16)

 

 Never

54(88.52)

33 (91.67)

21 (84)

 

Comorbidity, n (%)

 Hypertension

10 (16.39)

5 (13.89)

5 (20)

0.727

 Hyperglycemia

2 (3.28)

1 (2.78)

1 (4)

1.000

Pulmonary function

 FEV1b, L

2.33 (0.58)

2.27 (0.56)

2.41 (0.61)

0.186

 FEV1/FVCc (%)

77.41 (8.49)

76.52 (10.49)

78.67 (4.46)

0.278

Tumor size, cm

   

0.004**

 Mean ± SD

2.87 (1.29)

2.48 (1.04)

3.44 (1.04)

 

 Median (range)

2 (0.9-7)

2.2 (0.9-5)

3 (2-7)

 

Tumor location (lobe)

   

0.294

 Left upper

12

7

5

 

 Left lower

29

17

12

 

 Right upper

7

2

5

 

 Right middle

2

2

0

 

 Right lower

11

8

3

 
  1. The data was presented as mean (SD) or median (range)
  2. **P < 0.01. Continuous variables were compared using Student’s t test and categorical variables using chi-squared test
  3. a BMI body mass index
  4. b FEV1: the forced expiratory volume in 1 s
  5. c FEV1/FVC: the forced expiratory volume in 1 second (FEV1)/forced volume vital capacity (FVC) ratio